Form 4: OKYO Pharma Executive Receives Stock Grant
Insider Transaction (Form 4)
Gary S Jacob, CHIEF DEVELOPMENT OFFICER and a Director of OKYO Pharma Ltd, received 3,500 shares of common stock on July 21, 2026.
Summary
- Grant/award: acquired 3,500 COMMON STOCK at $1.40 ($4,900) on July 21, 2026; holds 112,420 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Gary S Jacob — Director, Officer (CHIEF DEVELOPMENT OFFICER)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-21 | Grant/award | COMMON STOCK | 3,500 | $1 | $4.9K | 112,420 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-21 | Grant/award (3,500 shares) |
Keywords
insider transaction, Form 4, OKYO, OKYO Pharma Ltd, neutral, Gary S Jacob
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.